Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Clarice Sinn, DO, of the University of Kentucky spoke about rehabilitation in rare neuroimmune disorders [00:00:05]. Dr. Sinn focused on electrical stimulation and explained three types: transcutaneous electrical nerve stimulation (TENS) for pain, neuromuscular electrical stimulation (NMES), and functional electrical stimulation (FES) [00:01:13]. She described how NMES helps weakened muscles, the settings that can be adjusted, electrode size and placement, possible side effects, home devices, and how she uses it with children, including those with acute flaccid myelitis [00:04:19]. She covered FES cycling, including its use at the bedside in intensive care units for newly diagnosed children, and research in spinal cord injury [00:10:54]. She also described walking and hand devices that use FES, and noted that insurance coverage varies [00:14:11].
Clarice N. Sinn, DO, MHA, is an associate professor of physical medicine and rehabilitation at the University of Kentucky, where she is medical director and division chief of pediatric rehabilitation medicine at Kentucky Children's Hospital. A pediatric rehabilitation physician, she earned her medical degree at Ohio University College of Osteopathic Medicine and practiced in Dallas for about eight years, working with Dr. Benjamin Greenberg, before joining the University of Kentucky.
00:00 Introduction by Dr. Pardo
00:48 Welcome and Topic Overview
01:59 Three Types of Electrical Stimulation
04:19 How Neuromuscular Stimulation Works
05:15 Settings and Electrode Placement
07:01 Muscle Fibers and Side Effects
09:02 Research and Home Devices
10:54 Functional Electrical Stimulation
13:18 Stimulation in the Intensive Care Unit
14:11 Walking and Hand Devices
16:54 Closing and Questions
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Clarice Sinn, DO, of the University of Kentucky spoke about rehabilitation in rare neuroimmune disorders [00:00:05]. Dr. Sinn focused on electrical stimulation and explained three types: transcutaneous electrical nerve stimulation (TENS) for pain, neuromuscular electrical stimulation (NMES), and functional electrical stimulation (FES) [00:01:13]. She described how NMES helps weakened muscles, the settings that can be adjusted, electrode size and placement, possible side effects, home devices, and how she uses it with children, including those with acute flaccid myelitis [00:04:19]. She covered FES cycling, including its use at the bedside in intensive care units for newly diagnosed children, and research in spinal cord injury [00:10:54]. She also described walking and hand devices that use FES, and noted that insurance coverage varies [00:14:11].
Clarice N. Sinn, DO, MHA, is an associate professor of physical medicine and rehabilitation at the University of Kentucky, where she is medical director and division chief of pediatric rehabilitation medicine at Kentucky Children's Hospital. A pediatric rehabilitation physician, she earned her medical degree at Ohio University College of Osteopathic Medicine and practiced in Dallas for about eight years, working with Dr. Benjamin Greenberg, before joining the University of Kentucky.
00:00 Introduction by Dr. Pardo
00:48 Welcome and Topic Overview
01:59 Three Types of Electrical Stimulation
04:19 How Neuromuscular Stimulation Works
05:15 Settings and Electrode Placement
07:01 Muscle Fibers and Side Effects
09:02 Research and Home Devices
10:54 Functional Electrical Stimulation
13:18 Stimulation in the Intensive Care Unit
14:11 Walking and Hand Devices
16:54 Closing and Questions
![2026 RNDS | Fatigue, Sleep, and Cognition
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Elena Grebenciucova, MD, of Northwestern Medicine spoke about fatigue, sleep, and cognition, and how closely the three are tied together. Dr. Grebenciucova explained how poor or interrupted sleep, including untreated obstructive sleep apnea, can affect mood, focus, and memory, and why a person with a rare neuroimmune disorder should not assume every bout of fatigue comes from the disorder itself [00:03:11]. She walked through the types of fatigue (physical, cognitive, emotional, and sleep-related) and common modifiable causes such as caffeine, medications for nerve pain and spasticity, bladder needs at night, chronic pain, and headaches [00:05:28]. She also covered eating patterns, vitamin B12 and vitamin D levels, thyroid function, anxiety and depression, and asking for a dedicated appointment to talk about fatigue [00:15:28]. The talk closed with ways to support thinking skills, including cognitive rehabilitation, aerobic exercise, and sleep supplements to discuss with a physician [00:22:46].
Elena Grebenciucova, MD, completed neurology residency at the University of Chicago in Chicago, Illinois. Dr. Grebenciucova has been interested in autoimmune disorders of the central nervous system, including rare neuroimmune disorders, since medical school. After residency, she completed a neuroimmunology fellowship under the mentorship of Dr. Brenda Banwell and Joseph Berger at the Perelman School of Medicine of the University of Pennsylvania. She is an assistant professor of Neurology (MS/Neuroimmunology) and neurological infections at Northwestern University in Chicago, Illinois, and runs the Transverse Myelitis Center there. Dr. Grebenciucova cares for people living with rare autoimmune conditions, including NMOSD, MOGAD, transverse myelitis, and autoimmune encephalitis.
00:00 Welcome and Introduction
01:51 Starting the Day with Positivity
03:11 How Sleep, Cognition, and Fatigue Connect
05:28 Types and Causes of Fatigue
08:44 Sleep Disorders and Sleep Apnea
10:16 Caffeine and Green Tea
12:04 Medications and Nighttime Bladder Needs
13:32 Chronic Pain and Headaches
15:28 Asking for a Dedicated Fatigue Appointment
16:46 Diet and Daily Habits
19:35 B12, Vitamin D, Thyroid, and Mood
21:25 Ways to Reduce Fatigue
22:46 Cognition and Brain Fog
25:10 Sleep Supplements and Closing 2026 RNDS | Fatigue, Sleep, and Cognition](https://i.ytimg.com/vi/g_QWYDywGkI/mqdefault.jpg)



![Community Meets Clinic 302. Drs. Grace Gombolay and Varun Kannan
The Community Meets Clinic podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode hosted by Krissy Dilger of SRNA, we met Dr. Grace Gombolay and Dr. Varun Kannan, both from Emory University and Childrens Healthcare of Atlanta, designated Centers of Excellence in Rare Neuroimmune Disorders. Dr. Kannan discussed learning alongside families as conditions like MOG antibody disease emerged clinically and his focus on tailoring treatment and supporting clinical trials in a field with few approved therapies [03:37]. Dr. Gombolay outlined her research on biomarker development, a Children’s biobank, advanced MRI collaborations, and participation in the Network of Pediatric MS Centers covering disorders such as MOGAD, NMOSD, optic neuritis, ADEM, and TM [06:36]. They described their multidisciplinary clinic team, highlighted home infusions and telemedicine to reduce burden, and shared personal self-care strategies [10:22]. Dr. Gombolay and Dr. Kannan expressed hope for more trials, remyelination, prevention, and earlier diagnosis aided by AI prompts [20:43].
You can view Dr. Grace Gombolays medical profile here:
https://www.choa.org/doctors/grace-gombolay
You can view Dr. Varun Kannans medical profile here:
https://www.choa.org/doctors/varun-kannan
Grace Gombolay, MD, MSc, FAAN is an Associate Professor at Emory University and Director of the Pediatric Neuroimmunology and Multiple Sclerosis Clinic at Childrens Healthcare of Atlanta. Her research interest involves biomarker development in pediatric neuroinflammatory diseases including autoimmune encephalitis, multiple sclerosis, MOGAD, and NMOSD.
Varun Kannan, MD graduated from Emory University School of Medicine in 2017. He then completed child neurology residency in 2022, followed by pediatric neuroimmunology and multiple sclerosis fellowship at Baylor College of Medicine and Texas Childrens Hospital in 2023. He returned to Emory and Childrens Healthcare of Atlanta in 2023, where he has worked closely with Dr. Grace Gombolay in the neuroimmunology program. He is interested in clinical research regarding severe/relapsing forms of rare neuroimmune disorders including autoimmune encephalitis and MOGAD. He is currently involved in multiple upcoming phase 3 clinical trials exploring new disease modifying treatments for pediatric rare neuroimmune disorders. He is also passionate about medical education and is currently one of the Associate Program Directors for the Emory child neurology residency.
00:00 Welcome
01:56 Dr. Grace Gombolays Journey
03:37 Dr. Varun Kannans Path
05:06 Kannans Research Focus
06:36 Biomarkers and Biobank
10:22 Clinic Team and Care
13:44 Self Care and Balance
16:15 Childrens Healthcare of Atlanta
20:43 Hopeful Future Ahead
24:49 Closing Community Meets Clinic 302. Drs. Grace Gombolay and Varun Kannan](https://i.ytimg.com/vi/hUrRjRHM69s/mqdefault.jpg)
![2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Carlos A. Pardo, MD, of Johns Hopkins University opened day two by explaining that the morning would focus on how people living with rare neuroimmune disorders can recover and keep doing what matters to them, rather than on spinal cord imaging, antibodies, or diagnostic criteria [00:00:35]. He noted that treatments such as plasma exchange, IV methylprednisolone, rituximab, and Ocrevus calm the immune system and help control progression, and that the harder question is how to continue a full, happy life afterward [00:01:24]. Dr. Pardo shared the vitamin P (positivity) and vitamin O he tells the people he treats are an important part of recovery after a diagnosis such as myelitis [00:02:10]. He described quality of life as a personal idea, from dancing with a daughter to watching a childs games, and asked what each person hopes to accomplish through rehabilitation [00:03:27]. He then ran two live audience polls, one on what has helped people feel supported and connected at RNDS and one on how people like to recharge after a full day [00:04:32].
Carlos A. Pardo, MD, is a Professor of Neurology and Pathology in the Division of Neuroimmunology and Neuroinfectious Disorders at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Director of the Johns Hopkins Myelitis and Myelopathy Center. He is the principal investigator of the Neuroimmunopathology Laboratory, a member of the HIV Neurosciences Research Group, and a clinical neurologist at the Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital. His clinical specialization is neuroimmunological and infectious disorders of the nervous system, with particular focus on multiple sclerosis, transverse myelitis, neurosarcoidosis, and neurological complications of autoimmune disorders.
00:00 Good Morning and Welcome Back
00:35 Focus for Day Two
01:24 Treatments and Recovery
02:10 Vitamin P and Vitamin O
03:27 What Quality of Life Means
04:04 Audience Poll on Feeling Supported
05:00 People and Conversation at RNDS
05:39 Audience Poll on Recharging 2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome](https://i.ytimg.com/vi/hiFZbmD6XAk/mqdefault.jpg)
![201. Steroid Dependence
In this ABCs of MOGAD episode, Steroid Dependence, Krissy Dilger of SRNA was joined by Dr. Eoin Flanagan from the Mayo Clinic in Rochester, MN. They began with a summary of how steroids are used to manage MOG antibody disease, particularly during acute attacks [00:01:25]. Dr. Flanagan described the mechanics of steroids in reducing brain inflammation and the importance of early treatment [00:04:14]. They discussed the concept of steroid dependence and the complications that arise when tapering down the steroid dose [00:05:46]. Dr. Flanagan highlighted alternative treatments to manage steroid dependence and emphasized the importance of working closely with healthcare providers to safely reduce steroid use over time [00:09:42].
Eoin Flanagan, MB, BCh is a Professor of Neurology and Consultant in the departments of Neurology and Laboratory Medicine and Pathology at the Mayo Clinic (Rochester, MN). He completed his medical school training at University College Dublin in Ireland in 2005. He did a medical residency in Ireland and then completed neurology residency, fellowships in neuroimmunology and a masters in clinical and translational science at Mayo Clinic (Rochester, MN). He works in the Autoimmune Neurology and Multiple Sclerosis Clinics and the Neuroimmunology Laboratory at the Mayo Clinic.
His clinical expertise and research are focused on inflammatory myelopathies and their imaging patterns, myelin oligodendrocyte glycoprotein (MOG) antibody associated disorder, neuromyelitis optica spectrum disorders, autoimmune encephalitis, paraneoplastic neurologic disorders, and multiple sclerosis. He is principal investigator on an NIH RO1 grant studying MOG antibody associated disorder.
00:00 Introduction
01:25 Understanding Steroids in MOG Antibody Disease
04:14 Steroid Dosage and Administration
05:46 Steroid Dependence in MOGAD Patients
09:42 Managing Steroid Dependence
14:02 Balancing Inflammation Control and Steroid Risks
17:31 Conclusion 201. Steroid Dependence](https://i.ytimg.com/vi/hkXutCNesok/mqdefault.jpg)
![2024 RNDS | What’s my Diagnosis? Physician Panel Discussion Based on Community Panel Presentations
At the 2024 RNDS, a panel of physicians discussed the community panel presentations on their diagnostic journey. The panel collectively discussed the importance of integrating patient stories with clinical perspectives to improve diagnosis and treatment of rare neurologic disorders [00:03:15]. Dr. Carlos Pardo shared historical insights and reviewed the evolution and challenges in understanding and diagnosing transverse myelitis over the past 20 years [00:06:23]. Dr. Dean Wingerchuk highlighted the journey and breakthroughs regarding neuromyelitis optica, emphasizing the significance of biomarkers and new diagnostic criteria [00:18:47]. Dr. Leslie Benson and others delved into acute flaccid myelitis, discussing how it overlaps and differentiates from other conditions, underscoring the importance of precise diagnostic methods and long-term management [00:35:12]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
00:00 Welcome and Introduction
01:13 Historical Perspective on Neurological Disorders
10:52 The Evolution of Neuromyelitis Optica
19:03 The Role of Diagnostic Testing
26:07 Acute Flaccid Myelitis: A New Challenge
37:43 The Importance of Accurate Diagnosis and Long-term Management
42:33 Advice for Patients and Families
46:01 Closing Remarks and Acknowledgements 2024 RNDS | What’s my Diagnosis? Physician Panel Discussion Based on Community Panel Presentations](https://i.ytimg.com/vi/iGsNACIp5Ds/mqdefault.jpg)
![2024 RNDS | Adaptive Tools and Resources
At the 2024 RNDS, Sandy Hanebrink discussed various adaptive tools and resources available for individuals with disabilities, including driving aids, home modifications, and vision technology [00:01:52]. She highlighted innovative devices such as OrCam and Glidance to assist with vision and mobility, as well as affordable solutions for adaptive grips and accessible computer access [00:07:16]. Sandy also mentioned adaptive recreation tools, including wheelchairs and accessible gaming controllers, as well as funding sources for these technologies [00:13:48]. She concluded by informing the audience about the Abilities Expo and providing her contact information for further assistance [00:20:15]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
You can view the presentation slides here:
https://files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Hanebrink.pdf
00:00 Introduction and Background
00:32 Adaptive Driving Tools and Resources
01:42 Home Modifications for Accessibility
04:59 Vision Tools and Technologies
10:27 Adaptive Grips and Computer Access
16:22 Accessible Gaming and Mounts
18:04 Wheelchairs and Mobility Aids
20:24 Adaptive Recreation and Sports
23:00 NextGen TV and Accessible Media
25:27 Funding and Resources
27:31 Conclusion and Contact Information 2024 RNDS | Adaptive Tools and Resources](https://i.ytimg.com/vi/ji5uHddIJF8/mqdefault.jpg)

